MannKind Announces CFO Transition

Steven B. Binder announces planned retirement and is appointed Executive Vice President, Special Projects, effective April 22, 2024, through Decem...

Related Keywords

Loyola Marymount University ,California ,United States ,Westlake Village ,Steve Binder ,Christopher Prentiss ,Stevenb Binder ,Michael Castagna ,Adamas Pharmaceuticals Inc ,Intermune Inc ,Adarx Pharmaceuticals Inc ,Linkedin ,Mannkind Corporation ,Dynavax Technologies Corporation ,Indiana University Kelley School Of Business ,Supernus Pharmaceuticals Inc ,Exchange Commission ,Facebook ,Mannkind Corporation Nasdaq ,Executive Vice President ,Special Projects ,Chief Financial Officer ,Kind Corporation ,Chief Executive ,Chief Executive Officer ,Chief Financial ,Adamas Pharmaceuticals ,Supernus Pharmaceuticals ,Indiana University ,Kelley School ,Annual Report ,